Loading clinical trials...
Loading clinical trials...
A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fasting Conditions
Conditions
Interventions
Zidovudine
Locations
1
United States
CEDRA Clinical Research
Austin, Texas, United States
Start Date
June 1, 2003
Primary Completion Date
June 1, 2003
Completion Date
June 1, 2003
Last Updated
January 23, 2018
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Roxane Laboratories
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions